Vision Loss News and Research

RSS

International coalition develops classification criteria for 25 subtypes of uveitis

An international coalition of eye researchers used machine learning to develop classification criteria for 25 of the most common types of uveitis, a collection of over 30 diseases characterized by inflammation inside the eye.

7 Jun 2021

High caffeine intake may increase the risk of glaucoma, finds study

Consuming large amounts of daily caffeine may increase the risk of glaucoma more than three-fold for those with a genetic predisposition to higher eye pressure according to an international, multi-center study.

7 Jun 2021

Optic nerve activity may trigger the formation of vision-harming tumors in children

In a study of mice, researchers showed how the act of seeing light may trigger the formation of vision-harming tumors in young children who are born with neurofibromatosis type 1 (NF1) cancer predisposition syndrome.

2 Jun 2021

Black fungus complicates India's COVID pandemic

India faces a global health crisis as the number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections reaches over 23.7 million. As India's health system buckles with increased admissions and a lack of resources, another health threat has emerged.

13 May 2021

New technique can help to non-invasively assess progression of sickle cell retinopathy

Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai have created a new technique to evaluate patients with sickle cell retinopathy and assess the disease before it progresses and leads to permanent vision loss.

10 May 2021

New photoreceptors from human pluripotent stem cells restores sight to injured retinas

Tens of millions of people worldwide are affected by diseases like macular degeneration or have had accidents that permanently damage the light-sensitive photoreceptors within their retinas that enable vision.

22 Apr 2021

Gene therapy for common forms of congenital blindness shows promise to improve vision

A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision, according to initial data from a clinical trial led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.

19 Apr 2021

Study finds that not all patients with elevated eye pressure need treatment to prevent vision loss

More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.

16 Apr 2021

Gene therapy may offer a new approach to preserving vision in people with retinitis pigmentosa

A gene therapy protects eye cells in mice with a rare disorder that causes vision loss, especially when used in combination with other gene therapies, shows a study published today in eLife.

13 Apr 2021

Early treatment with anti-VEGF injections slows diabetic retinopathy

Early treatment with anti-VEGF injections slowed diabetic retinopathy in a clinical study from the DRCR Retina Network (DRCR.net). However, two years into the four-year study its effect on vision was similar to standard treatment, which usually begins at the onset of late disease.

31 Mar 2021

Study identifies gene variants that cause metabolic deficiency in the eye

Treatments for a rare retinal disease may be on the horizon after a new study has identified gene variants that cause a metabolic deficiency in the eye.

25 Mar 2021

New AI platform can help assess vascular diseases

An international team of scientists from Nanyang Technological University, Singapore (NTU Singapore), Brown University and the Massachusetts Institute of Technology (MIT) has developed an artificial intelligence (AI) platform that could one day be used in a system to assess vascular diseases, which are characterised by the abnormal condition of blood vessels.

23 Mar 2021

NYSCF is developing new stem cell therapy to treat age-related macular degeneration

The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD).

22 Mar 2021

Researchers identify a genetic defect that increases the risk of debilitating eye disease

A genetic defect could hold the key to preventing or delaying the onset of a debilitating eye disease that can lead to vision loss and blindness.

16 Mar 2021

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma.

10 Mar 2021

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

A phase 2 clinical trial is underway at Columbia University and NewYork-Presbyterian to test an investigational gene therapy for dry age-related macular degeneration, a progressive, chronic eye disease with no cure and a leading cause of blindness in the United States.

9 Mar 2021

Vision Loss News and Research

International coalition develops classification criteria for 25 subtypes of uveitis

High caffeine intake may increase the risk of glaucoma, finds study

Optic nerve activity may trigger the formation of vision-harming tumors in children

Black fungus complicates India's COVID pandemic

New technique can help to non-invasively assess progression of sickle cell retinopathy

New photoreceptors from human pluripotent stem cells restores sight to injured retinas

Gene therapy for common forms of congenital blindness shows promise to improve vision

Study finds that not all patients with elevated eye pressure need treatment to prevent vision loss

Gene therapy may offer a new approach to preserving vision in people with retinitis pigmentosa

Early treatment with anti-VEGF injections slows diabetic retinopathy

Study identifies gene variants that cause metabolic deficiency in the eye

New AI platform can help assess vascular diseases

NYSCF is developing new stem cell therapy to treat age-related macular degeneration

Researchers identify a genetic defect that increases the risk of debilitating eye disease

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

Central retinal artery occlusion can be a warning sign of other vascular issues

A sneak peek of the current state and future use of artificial intelligence in pathology

New mobile app can help people diagnosed with glaucoma

People with vision impairment have higher risk of all-cause mortality

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News